Results 1 - 20 of 574 for All Library Resources
Sorted by:
Sorted by:
Date-oldestOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Refined by:
Journal Title:
Business Wire
subject:
Pharmaceutical Industry
subject:
Product Development
subject:
Pharmaceutical Industry
subject:
Product Development
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Newspaper Article
|
|
NORTH AMERICAN VACCINE ANNOUNCES NEW NIH RELEASE TO CLARIFY CLINICAL TRIAL RESULTSBusiness Wire, 1994-12-01, p.12011303COPYRIGHT 1994 Business Wire, Inc.Digital Resources/Online E-Resources |
| 2 |
Material Type: Newspaper Article
|
|
Large-scale trial establishes benefits of long-term management of prostate disease (PART V OF V)Business Wire, 1995-11-01COPYRIGHT 1995 Business Wire, Inc.Digital Resources/Online E-Resources |
| 3 |
Material Type: Newspaper Article
|
|
Large-scale trial establishes benefits of long-term management of prostate disease (PART III OF V)Business Wire, 1995-11-01COPYRIGHT 1995 Business Wire, Inc.Digital Resources/Online E-Resources |
| 4 |
Material Type: Newspaper Article
|
|
Large-scale trial establishes benefits of long-term management of prostate disease (PART I OF V)Business Wire, 1995-11-01COPYRIGHT 1995 Business Wire, Inc.Digital Resources/Online E-Resources |
| 5 |
Material Type: Newspaper Article
|
|
Large-scale trial establishes benefits of long-term management of prostate disease (PART IV OF V)Business Wire, 1995-11-01COPYRIGHT 1995 Business Wire, Inc.Digital Resources/Online E-Resources |
| 6 |
Material Type: Newspaper Article
|
|
FDA Vaccines Advisory Committee Unanimously Agrees That Clinical Data from 70,000-Infant Phase III Trials Support the Efficacy and Safety of ROTATEQ(R), Merck's Investigational Vaccine for Rotavirus GastroenteritisBusiness Wire, 2005-12-14COPYRIGHT 2005 Business Wire, Inc.Digital Resources/Online E-Resources |
| 7 |
Material Type: Newspaper Article
|
|
IDM Pharma Receives Special Protocol Assessment from FDA for Phase 2/3 Trial of Bexidem for Superficial Bladder CancerBusiness Wire, 2006-06-13COPYRIGHT 2006 Business Wire, Inc.Digital Resources/Online E-Resources |
| 8 |
Material Type: Newspaper Article
|
|
Hollis-Eden Pharmaceuticals Presents Positive Preclinical Data on Compounds Targeting Hormone Refractory Prostate CancerBusiness Wire, 2006-09-13COPYRIGHT 2006 Business Wire, Inc.Digital Resources/Online E-Resources |
| 9 |
Material Type: Newspaper Article
|
|
invivodata Initiates Set of ePRO Clinical Trials in Japan; Exclusive Relationship With Dendrite Japan Ensures Seamless Trial ExecutionBusiness Wire, 2006-09-14COPYRIGHT 2006 Business Wire, Inc.Digital Resources/Online E-Resources |
| 10 |
Material Type: Newspaper Article
|
|
Merck Revises Regulatory Filing Timeline for MK-0524B, an Investigational Fixed-Dose Combination of MK-0524A and SimvastatinBusiness Wire, 2006-09-29COPYRIGHT 2006 Business Wire, Inc.Digital Resources/Online E-Resources |
| 11 |
Material Type: Newspaper Article
|
|
Schering AG and Biogen Idec Announce Start of the ZEAL Phase III Clinical Trial With Anti-Cancer Drug Zevalin(R)Business Wire, 2006-10-05COPYRIGHT 2006 Business Wire, Inc.Digital Resources/Online E-Resources |
| 12 |
Material Type: Newspaper Article
|
|
IDM Pharma Submits New Drug Application to the FDA for Junovan(TM) (mifamurtide) in the Treatment of OsteosarcomaBusiness Wire, 2006-10-26COPYRIGHT 2006 Business Wire, Inc.Digital Resources/Online E-Resources |
| 13 |
Material Type: Newspaper Article
|
|
Synta Pharmaceuticals Announces FDA Fast Track Designation for STA-4783 in Metastatic MelanomaBusiness Wire, 2006-11-15COPYRIGHT 2006 Business Wire, Inc.Digital Resources/Online E-Resources |
| 14 |
Material Type: Newspaper Article
|
|
Depomed Announces Strong Positive Phase II Trial Results for Once Daily Gabapentin GR(TM) to Treat Symptoms of Diabetic Peripheral NeuropathyBusiness Wire, 2006-12-12COPYRIGHT 2006 Business Wire, Inc.Digital Resources/Online E-Resources |
| 15 |
Material Type: Newspaper Article
|
|
GenVec Announces Completion of Interim Safety Data Analysis for Phase II/III Trial with TNFerade(TM) in Pancreatic CancerBusiness Wire, 2006-12-14COPYRIGHT 2006 Business Wire, Inc.Digital Resources/Online E-Resources |
| 16 |
Material Type: Newspaper Article
|
|
Oscient Pharmaceuticals Completes Enrollment in Phase IV Trial of FACTIVE TabletsBusiness Wire, 2007-01-26COPYRIGHT 2007 Business Wire, Inc.Digital Resources/Online E-Resources |
| 17 |
Material Type: Newspaper Article
|
|
Phase III Trial of Progesterone for the Prevention of Preterm Birth in Women with a Previous Preterm Birth Earlier than 35 Weeks Does Not Meet EndpointsBusiness Wire, 2007-02-04COPYRIGHT 2007 Business Wire, Inc.Digital Resources/Online E-Resources |
| 18 |
Material Type: Newspaper Article
|
|
KAI Pharmaceuticals Presents Encouraging Phase 1/2 Results of a Novel Treatment for Heart AttackBusiness Wire, 2007-03-25COPYRIGHT 2007 Business Wire, Inc.Digital Resources/Online E-Resources |
| 19 |
Material Type: Newspaper Article
|
|
VEGF Trap-Eye Phase 2 Wet AMD Results Reported at ARVO Annual MeetingBusiness Wire, 2007-05-09COPYRIGHT 2007 Business Wire, Inc.Digital Resources/Online E-Resources |
| 20 |
Material Type: Newspaper Article
|
|
Second Phase III Study Evaluating Gilead's Viread(R) for the Treatment of Chronic Hepatitis B Virus Meets Primary EndpointBusiness Wire, 2007-06-25COPYRIGHT 2007 Business Wire, Inc.Digital Resources/Online E-Resources |
Results 1 - 20 of 574 for All Library Resources
Sorted by:
Sorted by:
Date-oldestOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Refine My Results
Creation Date
- Before 2006 (7)
- 2006 To 2010 (79)
- 2011 To 2014 (152)
- 2015 To 2019 (170)
- After 2019 (167)
-
More options
New Records
Subject
- Clinical Trials (339)
- Care And Treatment (198)
- Cancer (118)
- Medical Research (68)
- Drug Therapy (65)
- Biotechnology Industry (51)
- Health Aspects (51)
- Medicine, Experimental (48)
- Chemotherapy (48)
- Metastasis (47)
- Patient Outcomes (44)
- Antineoplastic Agents (41)
- Biological Products Industry (39)
- Antimitotic Agents (34)
- Immunotherapy (31)
- Infection (29)
- Lung Cancer, Non-Small Cell (27)
- Complications And Side Effects (24)
-
More options
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||